Back to Journals » Therapeutics and Clinical Risk Management » Volume 12

Spotlight on afatinib and its potential in the treatment of squamous cell lung cancer: the evidence so far

Total article views   HTML views PDF downloads Totals
15,559 Dovepress* 14,381+ 1,947 16,328
PubMed Central* 1,178 307 1,485
Totals 15,559 2,254 17,813
*Since 24 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed and Google Scholar